AG
SGYP

Advisor Group’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Advisor Group’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-34,514
Closed -$4K – 5452
2018
Q4 		$4K Sell
34,514
-12,200
-26% -$8.01K ﹤0.01% 4674
2018
Q3 		$79K Sell
46,714
-2,350
-5% -$4.21K ﹤0.01% 2936
2018
Q2 		$86K Sell
49,064
-24,750
-34% -$42.8K ﹤0.01% 2652
2018
Q1 		$136K Buy
73,814
+30,700
+71% +$64.8K ﹤0.01% 2292
2017
Q4 		$96K Sell
43,114
-536
-1% -$1.33K ﹤0.01% 2615
2017
Q3 		$127K Buy
43,650
+18,025
+70% +$61.5K ﹤0.01% 2213
2017
Q2 		$114K Buy
25,625
+5,150
+25% +$21.2K ﹤0.01% 2205
2017
Q1 		$96K Buy
20,475
+9,925
+94% +$57.6K ﹤0.01% 2188
2016
Q4 		$64K Buy
10,550
+1,800
+21% +$9.41K ﹤0.01% 2417
2016
Q3 		$48K Buy
8,750
+7,750
+775% +$36.3K ﹤0.01% 2580
2016
Q2 		$3K Buy
+1,000
New +$3.39K ﹤0.01% 4032

Other funds holding SGYP

TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Advisor Group's SGYP Position: Q1 2019 in Review

Advisor Group sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 34,514 shares — an estimated $4K sold.

Advisor Group first reported a position in SGYP in Q2 2016 and held it in 11 quarters. The position peaked at $136K in Q1 2018. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.

  • Advisor Group reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
  • Advisor Group sold 34,514 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $4K.
  • Advisor Group first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2016 and held it in 11 quarters.
  • Advisor Group's Synergy Pharmaceuticals, Inc Common Stock position peaked at $136K in Q1 2018.
  • 12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.

Based on Advisor Group's 13F filing for Q1 2019, filed 9 May 2019.